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PCLINICAL RESEARCH Coronary Artery Disease
Local Cytokine Concentrations
and Oxygen Pressure Are Related to
Maturation of the Collateral Circulation in Humans
Stephan H. Schirmer, MD, PHD,*§ Niels van Royen, MD, PHD,* Perry D. Moerland, PHD,†
Joost O. Fledderus, PHD,‡ José P. Henriques, MD, PHD,* René J. van der Schaaf, MD,*
Marije M. Vis, MD,* Jan Baan, JR, MD, PHD,* Karel T. Koch, MD, PHD,*
Anton J. G. Horrevoets, PHD,‡ Imo E. Hoefer, MD, PHD, Jan J. Piek, MD, PHD*
Amsterdam and Utrecht, the Netherlands; and Homburg/Saar, Germany
Objectives Our aim was to determine cytokine and oxygen gradients over the collateral circulation in humans.
Background The molecular background of the maturation of the collateral circulation in response to coronary narrowing is
poorly understood in humans, partly because of difficulties in obtaining local samples from the human collateral
circulation.
Methods Coronary collateral blood was sampled in 60 patients with nontotal (n  25) or total coronary occlusions (n  35)
using a special wide-lumen catheter. Coronary collateral flow index (CFI) was assessed by intracoronary pressure
measurements. Oxygenation and lactate content was measured as well as 30 cytokines potentially involved in
collateral artery growth, using a custom-made multiplex assay.
Results No rise in lactate or change in pH was found in collateral blood. Oxygen gradient between coronary and collat-
eral arterial blood correlated inversely with CFI (r  0.61, p  0.001). Locally increased plasma levels were
found for basic fibroblast growth factor, eotaxin, macrophage migration inflammatory factor, monocyte che-
moattractant protein-1, and transforming growth factor-beta, while stem cell factor and stem cell growth factor-
beta were significantly decreased. The highest cytokine gradients were found in patients with the least devel-
oped collateral circulation. The majority of cytokines correlated more strongly with the pO2 gradient across the
collateral bed than with CFI.
Conclusions Intravascular ischemia during brief balloon coronary occlusion is absent in human coronary collateral arteries.
The oxygen gradient found over the collateral circulation is increased in patients with a less matured collat-
eral circulation and relates to local levels of several known pro-arteriogenic cytokines. In case of a more
developed collateral circulation, relatively low levels of cytokines are present, suggesting that growth factor
therapy might be beneficial at this stage. (J Am Coll Cardiol 2009;53:2141–7) © 2009 by the American
College of Cardiology Foundation









tlthough mechanisms of arteriogenesis have been well
lucidated in experimental models, knowledge of cytokines
nd growth factors that mediate collateral artery growth in
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009, accepted February 16, 2009.umans is still limited (1). Also, the role of ischemia in
uman collateral artery growth is presently unknown. Local
lasma sampling directly from the human coronary collat-
ral circulation can provide such data. This is cumbersome,
See page 2148
owever, because of the poor accessibility of the collateral
irculation for blood sampling. Therefore, previous studies
ave investigated systemic cytokine levels in patients with
ifferent degrees of coronary collateralization. These studies
ave provided conflicting results, probably due to the fact
hat systemic levels of growth factors do not reliably reflect
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culation, as performed in previ-
ous studies, yielded only a small
volume of blood in a limited
percentage of patients. Such
small blood volumes have never-
theless allowed the analysis of a
few cytokines showing increased
levels of basic fibroblast growth
factor (bFGF) and transform-
ing growth factor (TGF)-beta
in the coronary collateral circu-
lation (4,5).
In the present study, to allow
analysis of a wide array of cyto-
kines potentially involved in hu-
man arteriogenesis, we have used
the Proxis catheter (St. Jude
Medical, St. Paul, Minnesota), a
wide-lumen suction catheter
originally developed as a proxi-
mal embolic protection device
(6), to obtain larger amounts of
blood from the collateral circula-
tion. In addition to plasma levels
of cytokines, the use of this cath-
eter facilitated additional blood
gas and lactate analyses of locally
sampled collateral blood, which
have not been performed previ-
ously in human coronary collat-
ral arteries. Together with the analysis of plasma cytokines,
hese metabolic parameters can provide valuable insights
nto the growth and functional status of the collateral
irculation in response to epicardial obstructions.
ethods
atient selection. This study was approved by the medical
thics committee of the Academic Medical Center, Am-
terdam, the Netherlands. Sixty Caucasian patients sched-
led for elective percutaneous coronary intervention for
table coronary artery disease (CAD) with symptoms of
ngina pectoris for 4 weeks were included after giving
nformed consent. Patients with a subtotal stenosis (70%)
ere selected if they had single-vessel CAD; patients with
hronic total occlusions (CTOs) had single-vessel or mul-
ivessel disease. Exclusion criteria were previous myocardial
nfarction in the area of collateralization, previous cardiac
urgery, severely depressed left ventricular function, diabetes
ellitus, neoplastic disease, and signs of inflammatory
llness.
ntracoronary instrumentation. After pre-dilation of the
tenosis, a 7-F (inner diameter 0.051 inches) proximal
mbolic protection device (Proxis catheter, St. Jude Medi-
Abbreviations
and Acronyms
bFGF  basic fibroblast
growth factor
CAD  coronary artery
disease
CFI  collateral flow index
CTO  chronic total
occlusion

















TGF  transforming growth
factor
TNF  tumor necrosis
factoral) was advanced through the guiding catheter and into the ereated coronary artery, which received collateral blood.
nflating a low-pressure (0.67 atm) balloon at the end of the
atheter temporarily stopped antegrade blood flow in the
rtery. Complete obstruction of antegrade blood flow was
nsured in a pilot study of 5 patients showing no contrast
ye entering the epicardial artery after balloon occlusion
data not shown). Subsequently, gentle suction was applied
anually to the proximal end of the catheter. The first 3 ml
spirated was discarded to prevent contamination with
ontrast medium or with blood already in the epicardial
essel before balloon occlusion (and thus not from the
ollateral circulation). Approximately 5 to 15 ml blood
depending on collateral flow) was then aspirated within
0 s. After deflation of the balloon, the catheter was
ithdrawn into the guiding catheter to obtain a control
ample from the coronary circulation. Blood was transferred
nto citrate tubes and centrifuged at 1,550 g for 30 min.
lasma was taken off carefully, aliquoted, snap frozen in
iquid nitrogen, and stored at 80°C. Collateral flow index
CFI) was measured as previously published (7).
xygen, pH, and lactate measurements. Immediately
fter aspiration, partial oxygen (pO2) and carbon dioxide
ressure (pCO2), pH, and saturation were measured from 1
ample per site per patient on a Rapidlab 865 (Siemens,
ermany). Lactate concentrations were measured using a
tandard clinical chemistry test.
ultiplex assay for the measurement of cytokine concen-
rations. A custom-made panel of 30 cytokines was mea-
ured using the Bio-Plex suspension array system (Bio-Rad
aboratories, Hercules, California) according to the manu-
acturer’s instructions as previously described (8). The panel
onsisted of interferon-alpha-2, hepatocyte growth factor,
acrophage colony-stimulating factor (MCSF), monocyte
nflammatory factor (MIF), monokine induced by gamma-
nterferon, nerve growth factor-beta, stem cell factor, stem-
ell growth factor-b, stromal cell-derived factor-1a, tumor
ecrosis factor (TNF)-alpha, TNF-beta, TNF-related
poptosis inducing ligand, interleukin (IL)-1b, IL-4, IL-6,
L-8, IL-10, IL-16, eotaxin, bFGF, granulocyte-macrophage
olony-stimulating factor (GM-CSF), interferon-gamma,
nterferon-gamma-inducible protein-10, monocyte che-
oattractant protein-1 (MCP-1), macrophage inflamma-
ory protein 1-alpha (MIP-1), MIP-1, platelet-derived
rowth factor, beta chain, regulated on activation, normal T
xpressed and secreted (RANTES), and vascular endothe-
ial growth factor. Plasma samples were thawed at room
emperature, diluted 1:1 in the manufacturer’s sample di-
uent, and incubated with bead-bound antibodies to previ-
usly mentioned cytokines for 60 min on a 96-well filter
late. After repeated washing, biotinylated detection anti-
ody was added, and the plate was incubated for another 60
in. Finally, streptavidin-PE (phycoerythrin) was pipetted
nto each well. After a short incubation, the constituents of
ach well were drawn up into the flow-based Bio-Plex
uspension array system, which identifies and quantifies
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June 9, 2009:2141–7 Collateral Oxygen and Cytokines in Humansescence. Data were analyzed using Bio-Plex Manager
oftware, version 3.0 (Bio-Rad Laboratories).
nzyme-linked immunosorbent assays (ELISAs). Be-
ause human interferon-beta and TGF-beta were not
epresented on our multiplex assay, we tested concentrations
f these cytokines using commercially available ELISA kits
Quantikine ELISA, R&D Systems, Minneapolis, Minne-
ota, and PBL Interferonsource, Piscataway, New Jersey)
ccording to the manufacturer’s instructions. Since the
oncentrations of bFGF were often found to be too low to
e properly detected with the multiplex system, a high
ensitivity ELISA assay was performed (HS Quantikine
LISA, R&D Systems) according to the manufacturer’s
nstructions. Briefly, samples were incubated on a 96-well
late coated with the appropriate antibody. After the
ecessary washing steps, a biotinylated antibody and subse-
uently streptavidin-conjugated horseradish-peroxidase
ere linked to the adherent probes. Using tetramethyl-
enzidine as a substrate, absorption was measured at 450
m in an EL808 spectrophotometer (BioTek, Winooski,
ermont).
tatistical analysis. Clinical characteristics are presented
s mean  SD or median and interquartile range for
uantitative variables and as observed numbers (%)
or nominal variables. Fisher exact test was used for
esting association in 2  2 contingency tables. From
O2, oxygen gradient was calculated as: pO2 gradient 
O2 coronary  pO2 collateral. pCO2 gradient was calculated
s: pCO2 gradient  pCO2 coronary  pCO2 collateral. Cyto-
ine gradients were calculated as: concentrationcollateral 
oncentrationcoronary. Oxygen and cytokine gradients
ere calculated on a logarithmic scale to correct for
kewed distributions. Oxygen and cytokine concentra-
ions are shown as median (interquartile range). Com-
arisons among 2 groups were performed by Student
test for normally distributed parameters and Wilcoxon
est for non-normally distributed parameters. Statistics
n cytokine concentrations were corrected for multiple
esting using Benjamini-Hochberg correction (9). False
iscovery rates were calculated and expressed as percent-
ge. Comparisons between 3 groups were performed by
nalysis of variance testing. Correlations were calculated
sing a Pearson correlation.
esults
atient characteristics. Sixty patients were included in the
tudy. Patients were age 61.0  11.4 years, and CFI ranged
rom 0.09 to 0.65 (mean value 0.31  0.12). Thirty-five
atients had a CTO of a coronary artery, while 25 had a
ubtotal stenosis (ranging from 60.1% to 91.5% diameter
tenosis in quantitative coronary angiography). All lesions
ndergoing intervention were proximal lesions, resulting in
rterial diameters of 3.0 to 4.0 mm. All CTO patients had
ufficient collateralization to prevent ischemia during bal-
oon occlusion as indicated by absence of ST-segment seviation, and no symptoms of angina pectoris at rest.
atients with a nontotal occlusion were grouped into
ollateral responders (CFI 0.21, n  13) and nonre-
ponders (CFI 0.21, n  12). ST-segment elevation
uring balloon occlusion (shown as median [interquartile
ange]) was significantly (p  0.001) different between
ollateral responders (0.0 [1.0] mm) and nonresponders (2.0
2.0] mm). Clinical baseline characteristics did not correlate
ith CFI and were not different between the 3 groups
nonresponders, responders, CTOs) (Table 1).
etabolic parameters in the coronary collateral circula-
ion. Oxygen pressure measurements were performed in 45
atients in total in this study. In the complete patient group,
verage pO2 was found significantly lower in the collateral
ample than in the coronary sample (10.2 [2.75] kPa vs.
1.3 [2.4] kPa; p  0.001). In contrast, lactate concentra-
ions were equal in coronary and collateral blood (0.94
mol/l vs. 0.91 mmol/l, p  NS), and also pH did not
iffer significantly (coronary: 7.42, collateral: 7.41, pNS).
actate and pH remained unchanged in collateral versus
oronary blood in collateral nonresponders, responders, and
atients with CTOs. There was no significant correlation
etween CFI and lactate (r  0.19, p  0.29) or CFI and
H (r  0.12, p  0.44). Also, pCO2 was not found
ifferent between proximal and distal sampling sites (5.18
s. 5.17 kP, p  NS).
Comparing the 3 patient groups, nonresponders showed
significantly higher oxygen gradient than responders or
TOs (2.24 [2.0] kPa vs. 1.63 [1.0] and 0.95 [0.77] kPa,
 0.003). In the patient group as a whole, a significant
nverse correlation was found between pO2 gradient and
FI (r  0.61, p  0.001) (Fig. 1). Similarly, an inverse
orrelation was found between oxygen saturation ratio and
FI (r  0.46, p  0.002). Conversely, the pCO2
radient did not correlate with CFI or oxygen gradient (r 
.17, p  NS) (Fig. 2).
ocal cytokine concentrations in the collateral circula-
ion. In the complete patient population, eotaxin, MCP-1,
IF, bFGF, and TGF-beta were found in significantly
igher plasma concentrations in the collateral specific sam-
les as compared with the coronary samples, while stem cell
actor and stem cell growth factor-beta were significantly
own-regulated (Table 2). Other cytokines measured did
ot show significant differences between collateral and
oronary samples. Interferon-beta was not detectable in
ither the coronary or the systemic sample in the majority of
atients (35 of 60 patients).
Dividing patients into the 3 groups (nonresponders,
esponders, CTOs) resulted in the highest collateral-
oronary gradients for all of the previously mentioned
ytokines in the nonresponders, followed by the responders,
hile patients with CTOs displayed smallest concentration
ifferences (Fig. 3).
roup-specific cytokine profiles in relation to CFI and
xygen gradient. In the patient group with nontotal occlu-
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oronary-collateral gradients of MCP-1, eotaxin, MIF,
IP-1, and hepatocyte growth factor. Conversely, a
egative correlation with oxygen gradient was found for
radients of nerve growth factor-beta and TNF-related
poptosis-inducing ligand (TRIAL) (Table 3). No cytokine
radient correlated significantly with CFI (data not shown)
n this group. After correction for multiple testing, none of
Figure 1 Oxygen Gradient Correlates With CFI
Partial oxygen (pO2) gradient is plotted against collateral flow index (CFI) in the
whole patient group. Patients with adequately developed collateral arteries
demonstrated low oxygen gradient, while collateral nonresponders had a high
oxygen gradient, resulting in a significant correlation.
aseline Characteristics
Table 1 Baseline Characteristics
Nonresponders (CFI <0.21, n  12)
Age, yrs 62.8 13.5
Male sex 9 (75)
Body mass index, kg/m2 27.2 2.6
Body surface area, m2 2.0 0.2
Hypertension 7 (58.3)
Hypercholesterolemia 5 (41.7)
Family history of CAD 10 (83.3)
Current smoker 4 (33.3)
Ex-smoker 6 (50)





Calcium antagonists 5 (41.7)
Nitrates 6 (50)
ACE inhibitors/ARBs 4 (33.3)
Diameter stenosis (QCA) (%) 72.4 9.4
C-reactive protein, mg/dl* 1.75 (0.7, 6.3)
Hemoglobin, mmol/l 8.63 0.61
Leukocytes, 109/l 6.6 1.9
Total cholesterol, mmol/l 4.0 0.9
linical characteristics were comparable between the 2 groups. Values are presented as n (%) or m
edian (first quartile, third quartile).
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; CAD  coronary
ngiography.he coronary-collateral cytokine gradients correlated with
xygen gradient (false discovery rate 25%) or CFI in
atients with CTO.
iscussion
n this study on the molecular background of the maturation
f the coronary collateral circulation in man, no changes in
Figure 2 Lack of Correlation Between Oxygen
Gradient and Carbon Dioxide Gradient
In contrast to pO2, partial carbon dioxide (pCO2) gradient over the collateral
circulation does not correlate with CFI. As shown in this figure, pCO2 gradient
also did not correlate with oxygen gradient over the collateral circulation (p 
0.25). Abbreviations as in Figure 1.
Responders (CFI >0.21, n  13) CTOs (n  35) p Value
62.6 11.4 59.8 10.9 0.63
8 (61.5) 24 (68.8) 0.80
27.0 2.8 27.1 4.2 0.99
2.0 0.1 2.0 0.3 0.71
8 (61.5) 22 (62.9) 0.92
8 (61.5) 15 (42.9) 0.54
8 (61.5) 19 (54.3) 0.24
1 (7.7) 5 (14.3) 0.44
7 (53.8) 19 (54.3) 0.44
12 (6, 65) 25 (11, 68) 0.41
10 (76.9) 27 (77.1) 0.53
12 (92.3) 31 (86.6) 0.78
12 (92.3) 32 (91.4) 1.0
11 (84.6) 22 (62.9) 0.18
3 (23.1) 8 (22.9) 0.42
6 (46.2) 19 (54.3) 0.88
4 (30.8) 15 (42.9) 0.70
74.9 9.2 100 0.0 0.001
1.4 (0.8, 3.5) 1.5 (1.0, 3.3) 0.75
8.75 0.42 8.75 0.65 0.84
7.2 1.3 6.9 1.7 0.62
3.9 0.8 4.2 0.9 0.63
SD unless otherwise indicated. *Indicates non-normal distribution; these values are presented as
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June 9, 2009:2141–7 Collateral Oxygen and Cytokines in Humansevels of pH or lactate were found in the collateral circula-
ion, showing that no intravascular ischemia is present in
he human collateral circulation. While pCO2 and pH were
nchanged in collateral versus systemic blood, pO2 was
ignificantly lower in collateral as compared with coronary
lood samples, suggesting local oxygen extraction in the
ollateral circulation. Oxygen gradient between coronary
nd collateral arterial blood correlated with CFI. Eotaxin,
FGF, MCP-1, MIF, and TGF-beta were found selectively
ncreased in collateral blood plasma, and cytokine levels in
he collateral circulation correlated well with oxygen gradi-
Figure 3 Cytokine Gradients
The box plot shows the relative change of collateral as compared with coro-
nary cytokine concentrations (significantly different cytokines for nonre-
sponders, responders, and chronic total occlusions [CTOs]). Concentrations
were log-transformed to correct for skewed parameter distributions and
improve visualization of median values with large interquartile ranges. Most
cytokine gradients were strongest in nonresponders and almost absent in
patients with CTOs. bFGF  basic fibroblast growth factor; MCP  monocyte
chemoattractant protein; MIF  macrophage migration inflammatory factor;
SCF  stem cell factor; SCGF  stem cell growth factor; TGF  transforming
growth factor.
ytokine Concentrations in the Collateral and Coronary Samples (i
Table 2 Cytokine Concentrations in the Collateral and Coronar
Cytokine Coronary Collateral
bFGF 3.32 (4.18) 10.49 (9.69)
MIF 91.75 (57.35) 111.02 (80.88)
Eotaxin 20.89 (32.14) 30.65 (50.78)
MCP-1 14.01 (4.31) 15.85 (9.95)
TGF-beta 3,830.62 (1,892.84) 4,161.25 (2,815.69)
SCF 359.50 (143.75) 283.84 (155.55)
SCGF-beta 2,624.00 (1,646.38) 2,349.57 (1,602.63)
ata are reported as median (interquartile range). Enhanced concentrations of basic fibroblast gro
rotein (MCP)-1, and transforming growth factor (TGF)-beta were found in collateral plasma, whil
isplays cytokine gradients in the complete patient group (n 60). Please note that due to calculat
ollateral and the median coronary cytokine concentration. The second column to the right indicaant. Collateral cytokine gradients were strongest in patients
ith insufficient collateral arteries and almost absent in
atients with CTOs.
atient selection. For a comprehensive analysis of human
rteriogenesis, we selected patients with single-vessel CAD
nd a severe coronary narrowing (nonresponders and re-
ponders) as well as patients with CTOs. This approach
llows an analysis of the collateral vascular development in 2
istinct clinical phases (i.e., during an accelerated phase in
-vessel disease and a more quiescent phase in chronic
oronary occlusion). Moreover, the analysis of cytokine
oncentrations was performed in a uniform fashion allow-
ng, for the first time, an interpretation of the adaptation of
ollateral vessels in a wide range of coronary narrowing.
atients with previous myocardial infarction, as shown by
chocardiography or pathological Q waves on electrocardio-
ram, were excluded from the study.
ollateral-specific blood sampling. The Proxis embolic
rotection device has been shown earlier to safely occlude
oronary vessels and provide retrograde blood aspiration
10). For the first time, we describe the use of the catheter
or the selective collection of coronary collateral blood.
revious studies using an over-the-wire catheter or a mul-
ifunctional probing catheter for coronary-collateral-specific
lood sampling resulted in limited amounts of blood and
ossible activation of the sample because of the small lumen
ml)
ples (in pg/ml)
Gradient Log-Ratio FDR (%)
6.82 (9.86) 2.09 (2.07) 0.1
22.25 (65.77) 0.37 (0.86) 0.2
3.48 (18.02) 0.20 (0.92) 0.2
1.57 (5.14) 0.16 (0.47) 0.2
493.25 (1,133.53) 0.19 (0.44) 2
29.26 (72.83) 0.14 (0.32) 0.1
83.98 (905.27) 0.07 (0.65) 2
tor (bFGF), macrophage migration inflammatory factor (MIF), eotaxin, monocyte chemoattractant
cell factor (SCF) and stem cell growth factor (SCGF)-beta were found to be decreased. The table
he median values and interquartile range, the gradient is not equal to the difference of the median
-transformed values that have been used for Figure 3.
orrelations of Collateral-Coronary Cytokineradients With Oxygen Gradie t in Patients Withubtotal Stenosis
Table 3
Correlations of Collateral-Coronary Cytokine
Gradients With Oxygen Gradient in Patients With
Subtotal Stenosis
Cytokine Correlation Coefficient p Value FDR (%)
MIF 0.59 0.01 11
Eotaxin 0.56 0.02 11
MCP-1 0.55 0.01 11
MIP-1 0.54 0.02 11
HGF 0.53 0.02 11
bNGF 0.57 0.02 11
TRAIL 0.54 0.02 11
good correlation was detected between gradients of several cytokines and oxygen gradient. Both
value and percentage FDR are mentioned. Note the negative correlation of the gradients of nerve




e stemHGF hepatocyte growth factor; MIPmacrophage inflammatory protein; other abbreviations











































































































2146 Schirmer et al. JACC Vol. 53, No. 23, 2009
Collateral Oxygen and Cytokines in Humans June 9, 2009:2141–7f the catheter (4,5). Using pericardial fluid or coronary
inus blood results in sufficient sample volumes that are,
owever, not selective for the collateral circulation (11,12).
In the clinical setting, catheter-assisted aspiration of
ollateral blood cannot exclude potential admixture of cap-
llary/venous blood, especially in patients with low CFI. The
act that in the present study the fall in pO2 is not
ccompanied by a rise in pCO2 or a decrease in pH in the
etrogradely drawn samples, however, makes significant
dmixture of venous blood less likely although contamina-
ion of a small amount of distal coronary capillary blood
annot be fully excluded.
We postulate that the gradient in arterial oxygen pressure
etween coronary and collateral arterial blood found in this
tudy rather relates to actual oxygen extraction along the
ollateral anastomoses. This corroborates experimental studies
lso reporting significant oxygen extraction along arteriolar
ystems (13,14). Local production of cytokines by the activated
ndothelium of the collateral circulation is an energy-
onsuming process. Indeed, in patients with a high oxygen
radient we also found the highest levels of cytokines.
ytokines in human arteriogenesis. The collateral-
pecific up-regulation of MCP-1, bFGF, and TGF-beta
onfirms earlier data on the involvement of these cytokines
n arteriogenesis (4,5). Other previously described pro-
rteriogenic cytokines, such as GM-CSF, granulocyte
olony-stimulating factor, and TNF-alpha, were not found
ifferential between the 2 sampling sites. Next to CCL2
MCP-1), we here also first describe enhanced expression of
nother CC-chemokine, CCL11 (eotaxin) in collateral
rteries. Its up-regulation in collateral arterial blood might
eflect a role in the fine-tuning of mononuclear cell homing,
artly counteracting the effects of MCP-1 (15). MIF has
arlier been described to stimulate angiogenesis, but a link
o collateral artery growth has not been reported previously
16). MIF acts as a major positive regulator of inflammatory
ell recruitment (17) and macrophage response to lipopoly-
accharide (18), both of which play an important role in
rteriogenesis.
ytokine expression in different phases of collateral
rtery growth. Since no intravascular ischemia could be
etected in the collateral arteries, collateral-specific expres-
ion of cytokines is not regulated by intravascular hypoxemia
r tissue ischemia directly adjacent to the collateral circula-
ion. However, ischemia in tissue distant from the major
ollateral arterioles still occurs, particularly in patients with
nonsufficient collateral circulation, as shown by ST-
egment elevation during balloon occlusion. Our findings
re in agreement with earlier results from experimental
tudies showing that arteriogenesis takes place proximal to
he site of tissue ischemia (19). Low oxygen gradient
etween coronary blood and blood in well-developed col-
ateral arteries demonstrated the physiological significance
f these bypass vessels, which are capable of supplying
yocardial tissue with normal oxygen concentrations. kInterestingly, cytokine concentrations in the collateral
irculation could be correlated to the oxygen gradient
etween coronary and collateral blood. We show that the
egree of collateral maturation is reflected by oxygen pres-
ure in the collateral artery. Cytokine gradients between
ollateral and coronary blood were greatest in nonre-
ponders and almost absent in CTO patients. The correla-
ion of cytokine concentrations with the oxygen extraction
hows strong arteriogenic activity where collateral vessels are
ot yet capable of providing sufficient oxygen levels. Those
ytokines that most significantly correlated with oxygen
radients were the same that were most strongly up-
egulated in collateral compared with coronary plasma.
nterestingly, a number of cytokine gradients were found to
nversely correlate with the oxygen gradient, suggesting a
otential antiarteriogenic role. In the chronic phase of
rteriogenesis (i.e., in CTOs), a reduction of cytokine
radients indicates that collateral artery growth has reached
plateau phase where less cytokines and growth factors are
ecreted. This is in line with the results of a study by Werner
t al. (5) showing higher bFGF concentrations in more
ecent occlusions, where arteriogenesis was presumably still
ngoing, as well as increased concentrations of MCP-1,
lacental growth factor, and TGF-beta in smaller collateral
rteries with higher shear stress. Even if CFI does not reach
igh levels in all patients, collateral artery growth may have
ome to a halt. This is consistent with earlier findings
howing a genetic predisposition of individual patients to
evelop an adequate or inadequate collateral circulation (7)
nd supports strategies in which local delivery of growth
actors/cytokines in the coronary circulation is striven for. In
hat earlier study, increased monocyte inflammatory signal-
ng was found in patients with weak collateralization, which
s supported by plasma measurements in the present study
howing increased cytokine gradients in insufficient collat-
ral development. Potentially, inhibition of antiarteriogenic
ignaling selectively at the site of interest is an alternative
reatment strategy for the stimulation of collateral artery
rowth.
ssessment of collateral flow index. Central venous pres-
ure (CVP) was assumed to be 5 mm Hg instead of
easuring CVP in every patient individually because of the
lready extensive study protocol. This assumption, however,
educes accuracy of the CFI measurements especially in
atients with low CFI (20,21). To evaluate if differences in
VP would significantly influence our study results, we
ecalculated correlations of CFI with pO2 and pCO2 gra-
ients as well as cytokine gradients using a CVP of 0, 5, and
0 mm Hg. Correlation of CFI with pO2 gradient was
lmost unchanged (R  0.60, p  0.001). Similarly,
hanging the CFI cutoff to 0.25 did not significantly
nfluence the results, still showing significantly different
xygen gradients (1.4 [1.8] vs. 2.1 [1.6]) in collateral
esponders versus nonresponders. Correlations with cyto-
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arying from 0 to 10.
tudy limitations. A limitation to pressure-derived CFI
easurements is reduced accuracy in low collateral flow,
hen back pressure increases due to increased wall stress,
hich may influence CFI measurements (22). No data on
eft ventricular end-diastolic pressure are available from the
resent study population as it requires additional intracavi-
ary instrumentation. However, patients with depressed left
entricular function on echocardiography were excluded
rom the study, which limits the possibility of variation in
ack pressure as a confounding factor in the present study.
Finally, applying negative pressure during intracoronary
lood withdrawal might have affected collateral flow rate,
hich potentially has led to an actual underestimation of the
O2 and cytokine gradients in patients with a low CFI.
onclusions
FI can directly be related to the gradient of oxygen
ressure over the collateral vascular bed. In patients with a
onsufficient collateral circulation, the increased oxygen
radient is accompanied by higher local levels of cytokines,
ointing to an active phase of arteriogenic remodeling. Less
ronounced cytokine gradients in collateral arteries in
TOs indicate a quiescent phase of arteriogenic activity,
hich supports strategies of local growth factor therapy in
hese patients.
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